City

Kashiwa (1)

Shanghai (1)

Condition

Advanced and Metastatic Solid Tumor (2)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Kohei Shitara (1)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1)

Collaborator

Bayer Yakuhin, Ltd. (1)

Ono Pharmaceutical Co. Ltd (1)

Intervention

fz-ad004 (1)

nivolumab (1)

regorafenib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

advanced and metastatic solid tumor

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced and Metastatic Solid Tumor Trial in Shanghai (FZ-AD004)

Not yet recruiting

Advanced and Metastatic Solid Tumor

FZ-AD004

Shanghai, China

Shanghai Chest Hospital

Jun 13, 2023

Advanced and Metastatic Solid Tumor Trial in Kashiwa (Regorafenib, Nivolumab)

Completed

Advanced and Metastatic Solid Tumor

Kashiwa, Chiba, Japan

NationalCCHE

Apr 23, 2021